Key Players Shaping CAR T-Cell Therapy Market | Gilead Sciences, 2Seventy Bio, Autolus Therapeutics
The global CAR T-cell therapy market is poised for significant expansion, valued at USD 2.25 billion in 2024 and projected to reach USD 11.49 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 17.7% over the forecast period. This growth is driven by the increasing incidence of cancer, strong product pipelines, and advancements in immunotherapy. According to the World...
0 Yorumlar 0 hisse senetleri 928 Views